Literature DB >> 12457915

Ciliochoroidal effusion induced by topical latanoprost in a patient with sturge-weber syndrome.

Hiroshi Sakai1, Nariko Sakima, Yoshimi Nakamura, Yuko Nakamura, Kazuhisa Hayakawa, Shoichi Sawaguchi.   

Abstract

BACKGROUND: To report drug-induced ciliochoroidal effusion in a patient with Sturge-Weber syndrome. CASE: A 17-year-old man presented with unilateral glaucoma associated with Sturge-Weber syndrome. OBSERVATIONS: His corrected visual acuity was RE 20/20 and LE 40/60. Intraocular pressure readings by Goldmann applanation tonometry were RE 32 mm Hg and LE 12 mm Hg. Fundus examination showed marked glaucomatous disc cupping in his right eye and normal finding in his left. The patient had a port-wine stain on his right upper eyelid ipsilateral to the glaucomatous eye. Antiglaucomatous medications were begun, including topical latanoprost, with a diagnosis of juvenile onset glaucoma associated with Sturge-Weber syndrome. Ultrasound biomicroscopy showed a 360 degrees circumference ciliochoroidal effusion. Forty days after starting medication, latanoprost treatment was discontinued. Ten days later, ultrasound biomicroscopy showed a total disappearance of the ciliochoroidal effusion.
CONCLUSION: Interaction of the enhanced uveoscleral outflow with latanoprost in conjunction with elevated episcleral venous pressure may have caused the congestion of the aqueous humor in the supraciliary-choroidal space, resulting in the ciliochoroidal effusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457915     DOI: 10.1016/s0021-5155(02)00542-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

Review 1.  Non-steroidal drug-induced glaucoma.

Authors:  M R Razeghinejad; M J Pro; L J Katz
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

Review 2.  [Glaucoma due to elevated episcleral venous pressure].

Authors:  R Greslechner; I Oberacher-Velten
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

3.  Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost.

Authors:  Rashmi Krishnamurthy; Sirisha Senthil; Chandrasekhar S Garudadri
Journal:  BMJ Case Rep       Date:  2015-07-14

4.  Focal venous hypertension as a pathophysiologic mechanism for tissue hypertrophy, port-wine stains, the Sturge-Weber syndrome, and related disorders: proof of concept with novel hypothesis for underlying etiological cause (an American Ophthalmological Society thesis).

Authors:  Cameron F Parsa
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

Review 5.  [Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-26       Impact factor: 1.059

Review 6.  Pediatric Glaucoma: Pharmacotherapeutic Options.

Authors:  Monica Samant; Anagha Medsinge; Ken K Nischal
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

7.  Ciliochoroidal effusion with persistent hypotony after trabectome surgery.

Authors:  Essam A Osman; Faisal AlMobarak
Journal:  Indian J Ophthalmol       Date:  2015-03       Impact factor: 1.848

8.  Acetazolamide-Induced Bilateral Ciliochoroidal Effusion Syndrome in Plateau Iris Configuration.

Authors:  Xiaofei Man; Raquel Costa; Bernadete M Ayres; Sayoko E Moroi
Journal:  Am J Ophthalmol Case Rep       Date:  2016-05-17

9.  Recurrent Uveal Effusion after Laser Iridotomy.

Authors:  Hiroshi Sakai; Michiko Yonahara; Miyako Sakai
Journal:  Case Rep Ophthalmol       Date:  2017-01-17

10.  Progressive retinal vessel malformation in a premature infant with Sturge-Weber syndrome: a case report and a literature review of ocular manifestations in Sturge-Weber syndrome.

Authors:  Zhengping Hu; Jian Cao; Eun Young Choi; Yun Li
Journal:  BMC Ophthalmol       Date:  2021-01-22       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.